SITUATION ANALYSIS: White Pill Wednesday Yesterday, Moderna and Merck announced an incredible result in cancer treatment. Their personalized mRNA cancer vaccine, intismeran autogene, substantially slowed recurrence of melanoma, the most serious type of skin cancer, in a Phase 3 clinical trial. The trial also showed a reduction in the risk of the cancer spreading to distant parts of the body. Moderna stock nearly tripled, surging 177% on the news. Merck rose 12.6%. Oncologists often say…